Seun Jeon Selected Research

Cerebral Cortical Thinning

1/2020	Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
1/2019	Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
12/2018	Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.
1/2015	Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
1/2015	Structural brain changes after traditional and robot-assisted multi-domain cognitive training in community-dwelling healthy elderly.
8/2013	Localized cortical thinning in patients with obstructive sleep apnea syndrome.
1/2012	Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seun Jeon Research Topics

Disease

13	Cognitive Dysfunction 01/2022 - 07/2013
10	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2013
9	Atrophy 01/2022 - 01/2012
9	Dementia (Dementias) 10/2021 - 06/2013
7	Cerebral Cortical Thinning 01/2020 - 01/2012
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2016 - 11/2013
3	Parkinson Disease (Parkinson's Disease) 05/2022 - 01/2019
3	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2021
2	Genetic Risk Score 05/2022 - 01/2021
1	Synucleinopathies 01/2021
1	Disease Progression 01/2019
1	Ischemia 04/2014
1	Lacunar Stroke 11/2013
1	Sleep Deprivation 08/2013
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2012

Drug/Important Bio-Agent (IBA)

16	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2012
5	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2020 - 11/2013
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2016 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2019
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2021 - 12/2018
3	Apolipoprotein E4IBA 10/2021 - 11/2013
3	Amyloid beta-PeptidesIBA 01/2021 - 11/2013
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	valrubicin (AD 32)FDA Link 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	SynucleinsIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	THK5351IBA 01/2019
1	florbetapirIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 11/2013
1	ApolipoproteinsIBA 11/2013
1	Oxygen (Dioxygen)IBA 08/2013

Therapy/Procedure

1	Gastrectomy 01/2019
1	Cognitive Training 01/2015